“We are advising the government of Madagascar to take this product through a clinical trial and we are prepared to collaborate with them,” Matshidiso Moeti, WHO’s regional director for Africa told in a statement.
“We would caution and advise countries against adopting a product that has not been through clinical tests for safety and efficacy,” she added.
“We are concerned about the impact that COVID-19 will have on the ability of African countries to progress towards Universal health coverage,” Moeti said.
“We know that to stop the spread of this virus, key public health measures need to be in place in every community… even where cases have not been reported, readiness capacities should be prepositioned.”
Moeti added that WHO was “working with countries to leverage the assets they have in place already, built in preparedness for Ebola and HIV, TB and polio program among others, as well as to scale-up coordination, mobilize people and repair supply chains globally and locally. It’s not a matter of simply today we have lockdowns and tomorrow everything is opened up. It has to be gradual with the most essential parts of the economy being opened up first.”
While education facilities still remain closed in most African countries, businesses have already been allowed to operate conditionally.